Chat real-time with other investors about DPHIQ, by clicking this link: http://www.stockwire.com/DPHIQ
DELPHI CORPORATION (PINKSHEETS: DPHIQ)
Delphi Corporation closed at $2.53 Tuesday, trading 1,188,347 shares
Company News- July 03, 2007: CORRECTION - Delphi Corporation
In the news release, "Delphi Vehicle Electronics and Safety Innovations Reach High-Volume Milestone With New Ford Mondeo," issued Monday, July 2, by Delphi Corporation, please be advised that the third paragraph should read "At the E/E Architecture's heart is a Smart Junction Box (SJB), which integrates microcontrollers for the CAN databus, lighting, central locking and theft protection functions. The SJB works as a gateway between the CAN High/Low Speed and LIN data busses which distribute signals throughout the vehicle with a speed and robustness optimized for each application," rather than "At the E/E Architecture's heart is a Smart Junction Box (SJB), which integrates microcontrollers for the CAN databus, lighting and alarm functions. The SJB works as a gateway between the High Speed, Media and Media CAN data-busses, which distribute signals throughout the vehicle with a speed and robustness optimized for each application." Additionally, the fourth paragraph should read "The Electrical/Electronic Architecture has 39 electronic modules with integrated memory and microelectronics to provide decision-making capability. One example of the benefits this provides is when a bulb fails the system immediately notifies the driver of the malfunction," rather than "The Electrical/Electronic system has 39 electronic modules, many of which include integrated memory and microelectronics to provide decision-making capability. One example of the benefits this provides is that when a bulb fails the system immediately notifies the driver of the malfunction. If it weren't prohibited by law, this system could activate a backup bulb at the same time," as originally issued incorrectly by Marketwire. Complete corrected text follows:
Delphi Vehicle Electronics and Safety Innovations Reach High-Volume Milestone With New Ford Mondeo
Delphi Corp. (PINKSHEETS: DPHIQ) will provide its advanced Electrical/Electronic Architecture and Smart Cruise Control for Ford of Europe's new Mondeo. The new vehicle also features Delphi wiring, actuators, body electronics, dampers, emission canisters and antenna. The new Mondeo was unveiled earlier this year at the Geneva Motor Show.
"Ford chose Delphi's E/E Architecture because it applies innovative design to deliver advanced functionality and high compatibility with the diagnosis and servicing requirements of the automotive repair shop. Furthermore, it is flexible enough to integrate any future functions that the vehicle manufacturer might add during a given vehicle generation," explains Stefaan Vandevelde, Managing Director, Delphi Electrical/Electronic Architecture, Europe. "The success of our work on the Ford Galaxy and Ford S-Max vehicles, which also feature Delphi E/E Architecture, helped to secure Delphi's role as a key development partner on this vehicle."
Delphi E/E Architecture provides power and signal distribution throughout the vehicle.
At the E/E Architecture's heart is a Smart Junction Box (SJB), which integrates microcontrollers for the CAN databus, lighting, central locking and theft protection functions. The SJB works as a gateway between the CAN High/Low Speed and LIN data busses which distribute signals throughout the vehicle with a speed and robustness optimized for each application.
The Electrical/Electronic Architecture has 39 electronic modules with integrated memory and microelectronics to provide decision-making capability. One example of the benefits this provides is when a bulb fails the system immediately notifies the driver of the malfunction.
To maximize passenger space, Delphi paid particular attention to packaging and routing. The E/E Architecture was developed with a new generation of smaller, lighter and more compact connectors, wiring, sensors and actuators. As a result, Delphi's E/E Architecture weighs up to 20 percent less than conventional E/E solutions, which contributes to better fuel economy and lower exhaust emissions. Delphi's E/E Architecture also uses less copper than conventional systems.
The first high-volume vehicle to be offered with such a sophisticated cruise control option.
The Mondeo also features Delphi's Smart Cruise Control with Forward Collision Warning: the first high-volume vehicle to be offered with such a sophisticated cruise control option. "Delphi's philosophy for active safety systems is to help drivers avoid accidents, and to make our roads safer by introducing these new safety technologies to a larger number of drivers. This is a milestone in the industry, beginning a trend where high-tech accident prevention technology is not just for the luxury market. As OEMS incorporate more of these active safety products into more vehicles, we believe the benefit to society will be demonstrated in reduced accident rates over time," explained Diedrich von Behr, Managing Director of Delphi Safety Systems, Europe.
Marketed as Adaptive Cruise Control (ACC) with Forward Alert (FA), the intelligent control system detects the relative speed of the vehicle ahead using a radar sensor embedded in the front bumper. In cruise mode, the system automatically adjusts vehicle throttle and braking to maintain a constant user-configured time gap of up to 2.5 seconds between vehicles. When cruise control is disengaged, the Delphi Collision Warning System provides the driver with audible and visible alerts if the driver approaches an unsafe distance to the vehicle ahead. Delphi's system uses high-precision scene interpretation software.
Delphi supplies a wide range of technologies to Ford as well as to its Jaguar, Land Rover and Volvo brands. Other systems Delphi supplies include active roll control and advanced air suspension for Land Rover and mechatronics and Passenger Occupant Detection sensing systems for Jaguar.
About Delphi Corp. (PINKSHEETS: DPHIQ)
Delphi is a leading global supplier of mobile electronics and transportation systems, including powertrain, safety, steering, thermal, and controls & security systems, electrical/electronic architecture, and in-car entertainment technologies. Engineered to meet and exceed the rigorous standards of the automotive industry, Delphi technology is also found in computing, communications, consumer electronics, energy and medical applications. Headquartered in Troy, Mich., Delphi has approximately 171,000 employees and operates 159 wholly owned manufacturing sites in 36 countries with sales of $26.4 billion in 2006. More information about the company can be found on its website at: www.delphi.com.
Chat real-time with other investors about CAMH, by clicking this link: http://www.stockwire.com/CAMH
CAMBRIDGE HEART, INC. (OTCBB: CAMH)
Cambridge Heart, Inc. closed at $4.31 Tuesday, trading 51,057 shares
Company News- July 03, 2007: Cambridge Heart to Present at the C.E. Unterberg, Towbin Emerging Growth Conference
Cambridge Heart, Inc., announced it will present at the C.E. Unterberg, Towbin Emerging Growth Conference at 3:30 p.m. Eastern Time on Thursday, July 12, at the Mandarin Oriental Hotel in New York.
Cambridge Heart's Interim Chief Executive Officer and Chairman of the Board, Robert Khederian, and Executive Vice President, Chief Operating Officer and Chief Technology Officer, Ali Haghighi-Mood, will be presenting. To access the live audio broadcast or the subsequent archived recording log onto http://www.wsw.com/webcast/ceut6/camh.ob/. Please connect to the website several minutes prior to the start of the conference call to ensure adequate time for any software download that may be necessary.
About Cambridge Heart, Inc. (OTCBB: CAMH)
Cambridge Heart, founded in 1990 and based in Bedford, Massachusetts, is engaged in the development and commercialization of products for the non-invasive diagnosis of cardiac disease, particularly the identification of those at risk of sudden cardiac arrest. The Company's products incorporate its proprietary Microvolt T-Wave Alternans measurement technologies, coupled with its patented Spectral Analytic Method and ultra-sensitive disposable electrode sensors. Only Spectral Analytic Method MTWA tests are reimbursed by Medicare under its National Coverage Policy that covers patients with a wide variety of cardiac symptoms. Other major insurers in the U.S. also have coverage policies for the test. The T-Wave Alternans test is included in the Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death jointly developed by the American College of Cardiology (ACC), the American Heart Association (AHA), and the European Society of Cardiology (ESC). More information can be found at: www.cambridgeheart.com.
Chat real-time with other investors about ERMX, by clicking this link: http://www.stockwire.com/ERMX
ENTREMETRIX, INC. (OTCBB: ERMX)
EntreMetrix, Inc. closed at $0.21 Tuesday, trading 797,079 shares
Company News- July 03, 2007: EntreMetrix Launches Nutritional Genomics Portfolio Investment with K-9 Genetics
EntreMetrix, Inc. announced the launch of a new portfolio investment within the ultra-premium dog food and treats industry.
The new portfolio company, K-9 Genetics, will develop personalized wellness programs that include Personalized Chowtm and Personalized Treatstm, functional foods that are nutritionally balanced to meet the exact needs of each unique dog.
The pet industry in the U.S. continues to exhibit strong and resilient growth, reaching an estimated $40 billion in 2006. Pet food represents $16 billion of this segment. Healthy and premium dog food and treats are growing the fastest, with $3.6bn in sales in 2005, up from $1.9bn in 1998, according to Euromonitor.
"In a market offering a $400 Puchi satchel and a $175/night stay at the Ritzy Canine Carriage House, I found it absurd how people literally feed waste' to their dogs. With the assistance of EntreMetrix, we're using the latest developments in science and technology to offer functional personalized diets," said Thomas McCarthy, Founder and CEO of K-9 Genetics Corp.
About EntreMetrix, Inc. (OTCBB: ERMX)
Based in Irvine, California, EntreMetrix is a Business Development Company, regulated under the Investment Company Act of 1940, and a provider of essential structural and financial support services to small business clients throughout the United States. The Company's structural support services create value for clients by providing expertise in the areas of employee and financial management, eliminating the need for clients to manage non-core functions. For more information on EntreMetrix, Inc., visit the Company's Web site at www.entremetrix.com or contact Scott W. Absher, (888) 798-9100. The Company's corporate offices are located in Southern California at 18101 Von Karman Avenue, Suite 330, Irvine, California 92612.
Chat real-time with other investors about BRVO, by clicking this link: http://www.stockwire.com/BRVO
BRAVO! BRANDS, INC. (OTCBB: BRVO)
Bravo! Brands, Inc. closed art $0.016 Tuesday, trading 3,401,119 shares
Company News- July 03, 2007: Bravo! Brands and Coca-Cola Enterprises, Inc. Agree to Termination of Master Distribution Agreement
Bravo! Brands, Inc. announced that it has reached an agreement with Coca-Cola Enterprises, Inc. ("CCE") to terminate the Master Distribution Agreement ("MDA") entered into by the parties on August 31, 2005. The termination of the MDA allows Bravo! to move forward to finalize its negotiations with a new national distributor for its products.
Ben Patipa, President of Bravo! commented: "The termination of our agreement with CCE was a joint decision between the two companies that reflects economic returns far below the expectations of both CCE and Bravo!. This termination of the MDA is a key step in our overall plan to restructure the business into an economically viable model through distribution with another national distributor."
The Company also announced that the warrants to purchase 30,000,000 shares of Bravo!'s common stock that were issued as part of the MDA relationship have been canceled in connection with the termination of the Master Distribution Agreement. No termination or cancellation fees will be paid by either party.
About Bravo! Brands, Inc. (OTCBB: BRVO)
Bravo! Brands Inc. develops, brands, markets, distributes and sells nutritious, flavored milk products throughout the United States. Bravo's products are currently sold under the brand names Slammers and Bravo!(TM). Bravo's Slammers products are available in many channels of trade including supermarkets, mass merchandisers, drug stores, convenience stores, gas stations, military, education and foodservice outlets. Many of Bravo! Brands' Slammers lines of shelf-stable, single-serve milk drinks are co-branded through exclusive partnerships with Masterfoods USA, a division of Mars Incorporated, General Mills, and Organic Valley, providing superior name recognition packaged with quality, great-tasting drinks.
Chat real-time with other investors about MNCL, by clicking this link: http://www.stockwire.com/MNCL
MARTIN NUTRACEUTICALS, INC. (PINKSHEETS: MNCL)
Martin Nutraceuticals Inc. closed at $0.014 Tuesday, trading 686,029 shares
Company News- July 03, 2007: Martin Nutraceuticals Launches New Book Sales Website www.medicalcrisisthebook.com
Martin Nutraceuticals Inc. announced that it has developed a specific website for handling the large volume of interest that they expect from their upcoming Infomercial on Dr. Martins future best seller - "Medical Crisis: Secrets your Doctor won't share with You."
Mr. Harvey Panesar, President of Martin Nutraceuticals, was enthusiastic in his comments about the new site. "Our new interactive website for book sales is www.medicalcrisisthebook.com . The Website is a work in progress; however the first step is complete so that the consumer can at least order the book. I can not fully tell you how excited I am that this project will soon be underway. We have poured a lot of time, money and energy into this project. Based on consumer feedback, we believe that it is going to be a very successful Infomercial."
Mr. Panesar went on to state that "Prior to the Infomercial airing, interested parties can purchase copies of the book on this new website. Advance sales have been brisk, with major retailers showing interest in stocking the book as well as Canada's largest book retailer(Chapters) already reordering the book. To date all comments about the book have been exceedingly positive." About Martin Nutraceuticals Inc. (PINKSHEETS: MNCL)
Martin Nutraceuticals Inc. is a company focused on providing a better health and lifestyle through natural products. Martin Nutraceuticals flagship products include Arthrizyme(TM) for general joint pain and Oxygenol(TM) for anti-oxidation and Maximum Slim(TM) for weight control. In the past few months the company has been producing an infomercial on best-selling author Dr. Anthony Martin's new book "Medical Crisis: Secrets our Doctor won't share with You." This amazing new book provides Dr. Martin's insights into the many things that an individual can eat and do in order to improve their health and wellness and that their medical doctor just does not have the time and resources to provide them. "Medical Crisis" is certainly life-altering and can possibly be life-saving.
To see the complete Movers & Shakers Blog go to: http://www.stockwire.com .
About Stockwire:
Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.